Corcept Therapeutics’ selective cortisol modulator failed to slow the progress of amyotrophic lateral sclerosis (ALS) in a ...

The U.S. Food and Drug Administration has approved Neurocrine Biosciences' drug to treat a type of genetic disorder, the ...

We all have unique schedules, challenges, and responsibilities. But there’s one thing almost everyone can relate to while ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe e ...

Avoiding the hunger trap and the binge-eating cravings is difficult. Overeating or eating unhealthy foods can often derail ...

Every purchase is backed by a 90-day refund policy. If you’re not satisfied, you can return the product hassle-free. This ...

Research from Washington University shows that glioblastoma, a type of brain cancer, has its own internal clock that ...

New research shows that glioblastoma has an internal clock and syncs its daily rhythms to match -- and take advantage of -- the rhythms of its host. In this way, brain tumors grow in response to the ...

Virtually every cell in the human body has an internal clock. These clocks take their cues from a central clock in the brain. In a normal, biological process called synchrony, the central clock ...

Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, leading to the release of stress hormones like cortisol ...

The US Food and Drug Administration has approved Crinecerfont for treatment ... require high doses of glucocorticoids (more ...